Across the cohorts, we observe that age at baseline (first AFP test), the proportion of white and black patients, the months between AFP tests and the baseline AFP, ALT and PLT were all similar within controls and HCC cases. This evidence concerns the gene GPT and hepatocellular carcinoma.